Company: SUPN
Filing Date: 2025-02-11
Form Type: 8-K
Source: 0001356576-25-000006
Chunk: 0

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-02-11
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On February 11, 2025, Supernus Pharmaceuticals, Inc. issued a press release announcing that it expects to report its business results for the fourth quarter and full year of 2024 after the market closes on Tuesday, February 25, 2025. The Company will host a conference call and webcast on Tuesday, February 25, 2025 at 4:30 p. m. E. T. to discuss its fourth quarter and full year 2024 financial and business results. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.